Journal article · 2026 · Open access
Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo
Neuroscience Letters, 882, 138645 · Published 29 May 2026 · DOI 10.1016/j.neulet.2026.138645
In brief
“Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo” is a 2026 journal article by Nicolas Fritz and 6 co-authors, published in Neuroscience Letters. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Neuroscience Letters.
- Citations
- 0
- References
- 32
- Authors
- 7
Abstract
Plaque deposits containing aggregated amyloid beta peptide (Aβ) fibrils are present in brain regions affected by Alzheimer's disease (AD). Lecanemab is a therapeutic monoclonal antibody that binds preferentially to soluble Aβ assemblies known as protofibrils, as well as to aggregated Aβ in amyloid plaques. Administration of lecanemab to individuals with early-stage AD reduces plaque burden and slows cognitive decline. The present study explored the role of immune cells in the mechanism of action of lecanemab using confocal microscopy, flow cytometry, and immunoassays. We show that lecanemab increases the internalization of synthetic Aβ42 protofibrils by human monocytic and mouse microglial cells, and that this effect is Fc gamma receptor-dependent. The Aβ42 protofibrils taken up by these cells were subsequently degraded within lysosomes. To investigate immune cell involvement in a system that resembled the clinical situation more closely, we evaluated the involvement of lecanemab in the removal of plaque pathology from sections of postmortem AD brain by primary human macrophages. Our results confirm that the lecanemab-mediated decrease in plaque pathology requires the presence of immune cells and is Fc gamma receptor-dependent. These data support the hypothesis that lecanemab's clinical effects involve Fc gamma receptor-dependent immune cell-mediated internalization and lysosomal degradation of Aβ protofibrils and plaques.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Fritz, N., Johannesson, M., Eriksson, F., Osswald, G., Lannfelt, L., Möller, C., & Söderberg, L. (2026). Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo. Neuroscience Letters, 882, 138645. https://doi.org/10.1016/j.neulet.2026.138645
MLA 9
Fritz, Nicolas, et al. “Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo.” Neuroscience Letters, vol. 882, 2026, p. 138645. https://doi.org/10.1016/j.neulet.2026.138645.
Chicago
Fritz, Nicolas, Malin Johannesson, Fredrik Eriksson, Gunilla Osswald, Lars Lannfelt, Christer Möller, and Linda Söderberg. 2026. “Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo.” Neuroscience Letters 882: 138645. https://doi.org/10.1016/j.neulet.2026.138645.
Harvard
Fritz, N. et al. (2026) ‘Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo’, Neuroscience Letters, 882, p. 138645. doi:10.1016/j.neulet.2026.138645.
IEEE
N. Fritz et al., “Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo,” Neuroscience Letters, vol. 882, p. 138645, 2026, doi: 10.1016/j.neulet.2026.138645.
BibTeX
@article{fritz2026lecanemab,
title = {{Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo}},
author = {Fritz, Nicolas and Johannesson, Malin and Eriksson, Fredrik and Osswald, Gunilla and Lannfelt, Lars and Möller, Christer and Söderberg, Linda},
journal = {Neuroscience Letters},
year = {2026},
volume = {882},
pages = {138645},
doi = {10.1016/j.neulet.2026.138645},
url = {https://doi.org/10.1016/j.neulet.2026.138645}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- lecanemab
- amyloid-beta protofibrils
- amyloid plaques
- Alzheimer's disease
- Fc gamma receptor
- microglia
- macrophages
- monocytic cells
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Fritz, N., Johannesson, M., Eriksson, F., Osswald, G., Lannfelt, L., Möller, C., & Söderberg, L. (2026). Lecanemab promotes Fc receptor-dependent cell-mediated internalization and degradation of aggregated amyloid-beta in vitro and ex vivo. Neuroscience Letters, 882, 138645. https://doi.org/10.1016/j.neulet.2026.138645
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Neuroscience Letters: sign in and open the full text from this page.
Who wrote this paper?
Nicolas Fritz, Malin Johannesson, Fredrik Eriksson, Gunilla Osswald, Lars Lannfelt, Christer Möller, Linda Söderberg.
What is the DOI of this paper?
10.1016/j.neulet.2026.138645, permanently at https://doi.org/10.1016/j.neulet.2026.138645. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.